Guoji Yanke Zazhi (Aug 2021)
Curative effect of Triamcinolone acetonide combined with macular grid photocoagulation in the treatment of macular edema secondary to BRVO
Abstract
AIM: To analyze the efficacy and safety of triamcinolone acetonide(TA)combined with macular grid photocoagulation in the treatment of macular edema(ME)secondary to branch retinal vein occlusion(BRVO).METHODS: A total of 147 patients(147 eyes)with ME secondary to BRVO treated in the hospital were enrolled between January 2016 and January 2020. They were randomly divided into observation group(73 eyes)and control group(74 eyes). The observation group was given intravitreal injection of TA and macular grid photocoagulation, while control group was given intravitreal injection of conbercept and macular grid photocoagulation. All were followed up for 6mo. Efficacy and safety indexes between the two groups were compared.RESULTS:After treatment, best corrected visual acuity(BCVA, LogMAR)in both groups was improved. At 1mo after treatment, BCVA in observation group was better than that in control group(0.22±0.15 vs 0.27±0.13, P0.05). After treatment, central macular thickness(CMT)in both groups was significantly decreased. At 3mo after treatment, CMT in observation group was higher than that in control group(309.76±84.24μm vs 258.75±88.76μm, P0.05). The incidence of increased intraocular pressure was higher in observation group than control group(28.8% vs 14.9%), and times of intravitreal injection were fewer than those in control group(1.21±0.74 times vs 3.62±2.08 times).CONCLUSION: TA combined with macular grid photocoagulation in the treatment of ME secondary to BRVO can maintain visual acuity at a certain level in the short term. The curative effect is comparable to that of conbercept combined with macular grid photocoagulation in terms of improving visual acuity and CMT. However, there is increased intraocular pressure, and the intraocular pressure monitoring needs to be strengthened.
Keywords